CLINICAL_TRIALS
trial_result
· 2026-06-16
Clinical Trial Results: Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery [Phase 2]
Summary
Phase 2 trial evaluating nivolumab as treatment for Stage IIB-IIC melanoma that can be surgically removed; results completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2026-06-16